Menora Mivtachim Holdings Ltd. Amgen Inc Transaction History

Menora Mivtachim Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $579,786 - $694,704	-3,330 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $20.6 Million - $24.1 Million	-123,385 Reduced 97.37%	3,330 $614,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $401,549 - $469,260	-2,370 Reduced 1.84%	126,715 $21.6 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $21.6 Million - $24.7 Million	129,085	129,085 $24.1 Million

3,097

406M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.